Related Experiment Video

Updated: Jun 22, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Surgical treatment for heart failure: left ventricular restoration for cardiomyopathy

Tadashi Isomura1

  • 1Cardiovascular Surgery, Hayama Heart Center, Hayama, Kanagawa 248-0116, Japan. t-isomura@hayamaheart.gr.jp

Circulation Journal : Official Journal of the Japanese Circulation Society
|May 29, 2009
PubMed

Insights

Surgical treatments for end-stage heart failure due to dilated cardiomyopathy (DCM) are evolving beyond heart transplantation. New left ventricular (LV) restoration procedures offer vital alternatives for managing DCM patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Technology

Background:

  • Congestive heart failure (CHF) presents a significant global health challenge.
  • Heart transplantation remains the sole surgical option for end-stage heart failure from dilated cardiomyopathy (DCM).
  • Donor organ scarcity necessitates alternative therapeutic strategies.

Purpose of the Study:

  • To review evolving surgical procedures for treating dilated cardiomyopathy (DCM).
  • To explore advancements in left ventricular (LV) restoration techniques.
  • To assess the role of non-transplant surgeries in DCM management.

Main Methods:

  • Literature search of published studies on left ventricular (LV) restoration.
  • Review of surgical procedures developed for DCM treatment since the 1980s.
  • Analysis of the evolution of surgical management for ischemic and non-ischemic DCM.

Main Results:

  • Left ventricular (LV) restoration was initially developed for ventricular aneurysm repair in the 1980s.
  • Multiple surgical techniques for DCM emerged in the 1990s.
  • Surgical interventions are increasingly important in 21st-century DCM care.

Conclusions:

  • Non-transplant surgical procedures are crucial for managing dilated cardiomyopathy (DCM) due to donor limitations.
  • Left ventricular (LV) restoration techniques represent a significant advancement in cardiac surgery.
  • Evolving surgical treatments are vital for improving outcomes in DCM patients.

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...